Len Neckers

Active 1976–2024

132
Papers
29,035
Citations
95
h-index
132
i10-index

Citations

Citations per year for Len Neckers1976: 1 citations1977: 1 citations1978: 2 citations1979: 1 citations1980: 2 citations1981: 3 citations1982: 4 citations1983: 3 citations1984: 21 citations1985: 25 citations1986: 16 citations1987: 24 citations1988: 14 citations1989: 18 citations1990: 34 citations1991: 47 citations1992: 50 citations1993: 49 citations1994: 47 citations1995: 38 citations1996: 52 citations1997: 88 citations1998: 128 citations1999: 147 citations2000: 160 citations2001: 147 citations2002: 186 citations2003: 274 citations2004: 334 citations2005: 387 citations2006: 337 citations2007: 335 citations2008: 383 citations2009: 397 citations2010: 389 citations2011: 456 citations2012: 409 citations2013: 367 citations2014: 357 citations2015: 288 citations2016: 307 citations2017: 237 citations2018: 273 citations2019: 750 citations2020: 682 citations2021: 648 citations2022: 522 citations2023: 332 citations2024: 548 citations2025: 288 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,281 citing papers, 35.7% of this breakdownChina: 951 citing papers, 10.3% of this breakdownUnited Kingdom: 543 citing papers, 5.9% of this breakdownGermany: 514 citing papers, 5.6% of this breakdownItaly: 374 citing papers, 4.1% of this breakdownFrance: 299 citing papers, 3.2% of this breakdownCanada: 285 citing papers, 3.1% of this breakdownJapan: 283 citing papers, 3.1% of this breakdownIndia: 248 citing papers, 2.7% of this breakdownSouth Korea: 179 citing papers, 1.9% of this breakdownSpain: 165 citing papers, 1.8% of this breakdownSwitzerland: 157 citing papers, 1.7% of this breakdown
0%35.7%Other 20.9%

Fields

  • Biochemistry, Genetics and Molecular Biology64.9%
  • Medicine23.2%
  • Immunology and Microbiology4.6%
  • Neuroscience2.3%
  • Computer Science1%
  • Chemistry1%
  • Other3%

Topics

  • Heat shock proteins research10.5%
  • Cancer, Hypoxia, and Metabolism3.8%
  • Endoplasmic Reticulum Stress and Disease3.3%
  • Computational Drug Discovery Methods3%
  • Ubiquitin and proteasome pathways2.4%
  • ATP Synthase and ATPases Research2.2%
  • Other74.8%

Coauthors

All papers

Open in search
  1. Targeting the dynamic HSP90 complex in cancer

    Authors: , , , - Nature reviews. Cancer 2010 cited by 1,528

  2. Structural and functional complexity of HSP90 in cellular homeostasis and disease

    Authors: , , , - Nature Reviews Molecular Cell Biology 2023 cited by 204

  3. Regulation and function of the human HSP90AA1 gene

    Authors: , , , - Gene 2015 cited by 353

  4. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

    Authors: , , , , , , , , , , , , - Cancer Cell 2005 cited by 942

  5. Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

    Authors: , - Clinical Cancer Research 2012 cited by 903

  6. An update on the status of HSP90 inhibitors in cancer clinical trials

    Authors: , , , , , , - Cell Stress and Chaperones 2024 cited by 103

  7. The Therapeutic Target Hsp90 and Cancer Hallmarks

    Authors: , , - Current Pharmaceutical Design 2012 cited by 343

  8. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 1,446

  9. HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation

    Authors: , , , , , , , , , , , , - Scientific Reports 2018 cited by 148

  10. Drugging the Cancer Chaperone HSP90

    Authors: , , , - Annals of the New York Academy of Sciences 2007 cited by 522

  11. Update on Hsp90 Inhibitors in Clinical Trial

    Authors: , , , , , , - Current Topics in Medicinal Chemistry 2009 cited by 307

  12. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90

    Authors: , , , , , , , , - Journal of Clinical Investigation 2009 cited by 242

  13. An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function

    Authors: , , , , , , , , , , , - Molecular Cell 2007 cited by 411

  14. IL‐1ÎČ mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis

    Authors: , , , , - The FASEB Journal 2003 cited by 675

  15. Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness

    Authors: , , , , , , , , , , , , , - Nature Cell Biology 2004 cited by 595

  16. Curcumin is an Inhibitor of p300 Histone Acetylatransferase

    Authors: , , , , , , - Medicinal Chemistry 2006 cited by 307

  17. Post-translational modifications of Hsp90 and their contributions to chaperone regulation

    Authors: , - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011 cited by 290

  18. Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2014 cited by 130

  19. Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development

    Authors: , , , , , - Cell Stress and Chaperones 2018 cited by 128

  20. Swe1Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function

    Authors: , , , , , , , , , , , , , , , , , , - Molecular Cell 2010 cited by 195

  21. Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein–Protein Interactions with Heat Shock Protein 70 (Hsp70)

    Authors: , , , , , , , , , , , , - Journal of Medicinal Chemistry 2018 cited by 120

  22. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 430

  23. Hsp90 inhibitors as novel cancer chemotherapeutic agents

    Authors: - Trends in Molecular Medicine 2002 cited by 674

  24. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells

    Authors: , , - Trends in Cell Biology 2014 cited by 140